primari
rhesu
monkey
kidney
mk
cell
long
cell
choic
isol
propag
human
paramyxovirus
parainfluenza
mump
howev
problem
suppli
cost
mk
cell
presenc
endogen
virus
includ
herp
b
viru
necessit
search
altern
cell
line
continu
cell
cultur
human
origin
hek
rd
simian
origin
vero
evalu
capac
support
growth
human
paramyxovirus
follow
cytopath
effect
hemadsorpt
hemagglutin
eia
human
lung
mucoepidermoid
carcinoma
cell
atcc
prove
sensit
line
cultiv
serotyp
strain
paramyxovirus
cell
also
shown
suitabl
substitut
mk
primari
isol
paramyxovirus
clinic
specimen
trypsin
prefer
mainten
medium
altern
eagl
mem
supplement
ggml
trypsin
satisfactori
cell
continu
line
excel
growth
characterist
although
genet
polyploidi
cell
may
limit
number
passag
usabl
cell
human
paramyxovirus
readili
isol
primari
rhesu
monkey
kidney
mk
cell
cultur
addit
sensit
mk
cell
particularli
valuabl
paramyxoviru
isol
viru
growth
visual
cytopatholog
cpe
hemadsorpt
fact
human
parainfluenzavirus
first
isol
vervet
rhesu
mk
cell
mumpsviru
initi
recov
rhesu
monkey
parainfluenza
present
address
biokit
sa
barcelona
spain
empar
castel
et
al
type
gener
recover
mk
cell
parainfluenza
mump
virus
isol
sever
human
simian
cell
line
mk
cell
howev
current
fraught
sever
problem
adequ
solut
evid
trap
rhesu
monkey
india
discourag
preserv
speci
nativ
habitat
b
primat
carri
mani
endogen
virus
adventiti
agent
eg
adenovirus
herpesvirus
includ
cmv
papovavirus
myxovirus
enterovirus
carri
risk
infect
laboratori
worker
handl
anim
tissu
exampl
problem
worker
contract
monkey
b
viru
herpesviru
simia
harmless
monkey
usual
fatal
man
well
known
c
kidney
rhesu
monkey
sometim
latent
infect
adenovirus
enterovirus
herpesvirus
almost
alway
infect
myxoviru
papovaviru
although
two
agent
known
infect
man
often
compromis
viru
isol
identif
work
reagent
product
vaccin
test
thu
constitut
major
builtin
viral
contamin
problem
laboratori
despit
establish
breed
coloni
us
use
monkey
sole
kidney
gener
regard
wast
cruel
e
monkey
expens
feed
hous
prepar
primari
cell
cultur
laborintens
costli
endeavor
despit
util
mk
cell
past
problem
necessit
search
altern
cell
line
paramyxoviru
isol
studi
report
use
cell
suitabl
substitut
mk
cell
primari
isol
laboratori
cultiv
human
paramyxovirus
prototyp
strain
human
paramyxovirus
obtain
refer
viru
collect
although
earliest
passag
avail
mk
cell
parainfluenzaviru
adapt
embryon
egg
low
passag
materi
eggadapt
virus
use
start
viru
studi
free
adventiti
agent
total
isol
repres
wide
time
place
distribut
also
obtain
refer
viru
repositori
strain
parainfluenza
mumpsviru
isol
mk
cell
store
sinc
time
cell
type
chosen
studi
tabl
obtain
inhous
american
type
cultur
collect
atcc
rockvil
md
cell
prepar
weekli
tube
cultur
fb
growth
media
inhous
cell
special
medium
recommend
atcc
cell
cell
use
monolay
confluent
inocul
growth
medium
decant
monolay
wash
mainten
medium
use
ml
seed
viru
inoculum
ml
origin
specimen
adsorb
cell
h
ambient
temperatur
ml
mainten
medium
ad
tube
incub
roller
drum
cultur
read
daili
cpe
first
trial
util
mainten
medium
consist
medium
fb
previous
titrat
hemagglutinationinhibit
hi
free
bovin
parainfluenza
antibodi
later
trial
employ
eagl
minim
essenti
medium
emem
supplement
lglutamin
penicillin
streptomycin
tgml
ggml
ggml
selen
acid
final
concentr
collabor
research
inc
lexington
ggmi
trypsin
sigma
chemic
co
st
loui
mo
trypsin
store
concentr
form
final
experi
done
medium
gibco
lab
grand
island
ny
antibiot
ggml
trypsin
virus
kept
cold
inocul
maintain
consist
within
oper
minim
loss
titer
labil
virus
viz
parainfluenza
mump
day
tube
scrape
blindpass
ml
per
tube
tube
weekli
interv
chosen
subpassag
consist
wellknown
paramyxoviru
replic
featur
usabl
lifespan
mani
cell
cultur
end
passag
one
tube
wash
pb
hemadsorb
guinea
pig
erythrocyt
fresh
cell
suspens
pb
read
taken
min
room
temperatur
two
scrape
pool
includ
supern
first
tube
subpassag
six
serial
passag
done
portion
passag
save
subsequ
compar
test
ascertain
viru
replic
addit
cpe
hemagglutin
ha
enzym
immunoassay
eia
viru
infect
titrat
carri
measur
extent
viral
replic
cultur
ha
titrat
perform
accord
standard
microtit
ha
procedur
use
phosphatebuff
salin
pb
ph
diluent
fresh
guinea
pig
human
erythrocyt
chicken
red
blood
cell
h
incub
room
temperatur
eia
parainfluenza
perform
polystyren
flatbottom
microtit
plate
immulon
dynatech
laboratori
alexandria
va
coat
lal
purifi
igg
typespecif
hors
antisera
eia
parainfluenza
mump
perform
except
biotinavidin
system
captur
igg
purifi
guinea
pig
antiserum
parainfluenza
ferret
antiserum
type
hors
antiserum
mump
ad
optim
dilut
carbon
buffer
incub
overnight
plate
wash
viral
control
antigen
ad
incub
wash
step
tl
correspond
biotinyl
guinea
pig
ferret
hors
igg
dilut
pbsgt
ad
plate
incub
h
remaind
test
done
previous
describ
infect
titrat
carri
serial
tenfold
dilut
viru
cultur
made
emem
inocul
ml
quadrupl
onto
appropri
cell
monolay
h
adsorpt
room
temperatur
ml
mainten
medium
ad
per
tube
cultur
incub
roller
drum
titer
read
cpe
calcul
reedmuench
method
empar
castel
et
al
cell
line
chosen
initi
evalu
basi
morpholog
deriv
carcinoma
tissu
deriv
simian
kidney
tissu
tabl
fresh
tube
cultur
cell
wash
mainten
medium
emem
ggml
trypsin
inocul
prototyp
strain
moi
cultur
read
daili
cpe
trypsin
level
toxic
mani
cell
type
experi
repeat
vari
dose
ggml
final
concentr
gener
ggml
highest
concentr
trypsin
toler
cell
six
sequenti
passag
virus
cell
made
presenc
ggml
trypsin
evalu
use
cpe
indic
viru
growth
confluenc
viabil
indic
healthi
cell
control
tabl
mani
cell
line
rd
grew
virus
slow
form
monolay
began
slough
day
cultur
unread
elimin
test
remain
ceil
inocul
paramyxovirus
presenc
highest
level
trypsin
could
toler
still
hek
vero
line
support
growth
parainfluenzavirus
viru
replic
cell
markedli
reduc
absenc
trypsin
medium
adsorptionentri
phase
data
shown
cell
support
growth
prototyp
strain
next
trial
compar
cell
directli
mk
cell
sequenti
passag
prototyp
strain
tabl
six
passag
done
sure
inoculum
dilut
could
observ
increas
antigen
titer
would
reflect
viral
replic
antigen
test
perform
passag
cell
parallel
ensur
accur
comparison
valu
passag
shown
tabl
cell
thu
shown
propag
paramyxovirus
higher
titer
continu
line
titer
equival
obtain
mk
cell
b
maintain
laboratori
without
special
measur
c
produc
cell
monolay
easi
read
cpe
cell
morpholog
distinguish
erythrocyt
test
next
test
abil
cell
support
growth
divers
paramyxoviru
isol
obtain
mk
cell
period
geograph
spread
virus
subpassag
time
mk
cell
parallel
passag
assay
cpe
ha
titrat
eia
result
indic
number
isol
recover
cell
type
end
passag
tabl
strain
parainfluenza
recov
first
second
passag
celt
system
strain
parainfluenza
mump
requir
passag
expect
gener
labil
virus
virus
recov
except
strain
mump
mk
cell
cell
thu
cell
clearli
suscept
broad
rang
strain
review
diagnost
featur
differ
serotyp
cell
reveal
trend
type
cpe
pattern
titer
ha
final
phase
studi
prospect
comparison
cell
mk
cell
incom
clinic
specimen
tabl
specimen
process
routin
procedur
inocul
cell
mk
cell
subpassag
test
cell
parallel
parainfluenza
ident
result
obtain
cell
line
although
virus
detect
mk
cell
slightli
less
time
cell
mumpsviru
cell
gave
clearer
cpe
less
time
mk
cell
strain
parainftuenza
recov
commun
period
test
stock
paramyxovirus
prepar
cell
evalu
paramet
electron
microscopi
ascertain
use
seed
virus
tabl
virus
prepar
pool
infect
cultur
u
uniform
p
patchi
hemadsorpt
rain
b
ha
titer
reciproc
highest
dilut
antigen
cultur
supernat
exhibit
complet
agglutin
chicken
guinea
pig
human
erythrocyt
h
ambient
temperatur
c
eia
titer
note
highest
dilut
antigen
exhibit
pn
positiveneg
valu
infect
titer
note
per
ml
day
incub
roller
cultur
altern
cell
line
paramyxoviru
harvest
one
freezethaw
cycl
day
incub
new
seed
virus
hightit
activ
test
consist
typic
intact
paramyxoviru
electron
microscopi
devoid
bacteri
fungal
mycoplasm
contamin
extens
cultur
appropri
media
eia
hi
breakthrough
neutral
test
paramyxoviru
antisera
show
crosscontamin
within
group
virus
data
tabl
obtain
replic
test
vial
viru
total
two
freezethaw
cycl
ha
eia
titer
consist
higher
sampl
multipl
freezethaw
cycl
storag
week
data
show
viru
seed
prepar
cell
equal
viru
titer
formerli
prepar
mk
cell
antigen
test
gave
equal
parallel
result
although
mk
data
shown
paramet
employ
select
new
cell
line
base
util
clinic
virolog
laboratori
cell
stock
readili
maintain
adequ
reserv
could
frozen
back
futur
use
b
cell
stabil
incub
period
import
paramyxovirus
fairli
slowgrow
requir
day
cultur
becom
evid
c
virusinduc
cpe
ideal
obviou
importantli
host
cell
nuclei
distinct
erythrocyt
use
test
presenc
viru
could
detect
reliabl
mk
cell
final
cell
suscept
infect
serotyp
human
paramyxovirus
select
cell
type
evalu
studi
consid
natur
pathogenesi
paramyxoviru
infect
man
name
virus
first
becom
establish
mucou
membran
nose
throat
therefor
epitheli
cell
site
would
like
candid
sensit
cell
sever
infect
lower
respiratori
tract
involv
therefor
human
lung
cell
might
use
human
rhesu
kidney
cell
sensit
paramyxovirus
cell
line
deriv
primari
tumor
cell
site
candid
use
select
cell
deriv
african
green
vervet
monkey
primari
african
green
kidney
cell
known
less
sensit
primari
rhesu
kidney
cell
isol
paramyxovirus
consider
also
given
previou
studi
shown
promis
vero
cell
cell
other
mani
cell
adequ
poor
growth
characterist
addit
support
growth
human
paramyxovirus
consist
pattern
lack
viru
growth
except
parainfluenza
difficult
grow
cell
even
mk
parainfluenza
mump
least
difficult
known
previou
experi
cell
evalu
may
empar
casteu
et
al
subject
high
passag
level
becom
less
differenti
possibl
lost
specif
receptor
site
need
paramyxoviru
attach
may
account
failur
hand
grow
parainfluenza
vero
cell
contrast
good
success
earlier
studi
cell
evalu
cell
atcc
support
growth
human
paramyxovirus
cell
continu
line
mucoepidermoid
carcinoma
cell
deriv
human
lung
possess
mani
characterist
origin
consid
continu
cell
human
respiratorytract
origin
rel
unknown
cell
line
use
previous
hepat
b
antigen
transfect
although
cell
initi
grown
medium
contain
insulin
transferrin
selenium
found
unnecessari
either
cell
mainten
viru
replic
studi
instead
satisfactori
growth
mainten
medium
trypsin
consid
import
addit
medium
earlier
studi
report
significantli
enhanc
replic
number
virus
treatment
presenc
trypsin
although
mk
cell
requir
trypsin
support
growth
orthomyxovirus
paramyxovirus
influenzaviru
activ
trypsin
cell
chick
embryo
cell
mdck
vero
paramyxovirus
enhanc
trypsin
vero
level
trypsin
use
vari
greatli
virus
cell
type
laboratori
procedur
studi
found
trypsin
essenti
replic
paramyxovirus
cell
either
emem
rpmi
mainten
media
final
protocol
cultur
human
paramyxovirus
cell
consist
grow
cell
confluent
monolay
medium
fc
decant
growth
medium
rins
cell
ml
mainten
medium
tgml
trypsin
inocul
ml
specimen
adsorb
h
ambient
temperatur
ad
ml
mainten
medium
incub
rocker
roller
drum
cultur
follow
cpe
day
subpassag
provid
maximum
viru
recoveri
prefer
subpass
weekli
interv
hemadsorb
guinea
pig
erythrocyt
usual
studi
demonstr
cell
promis
substitut
primari
rhesu
monkey
kidney
cell
tbr
isol
propag
human
paramyxovirus
initi
clinic
studi
also
suggest
cell
line
support
primari
isol
broad
rang
virus
includ
adenovirus
enterovirus
rhinovirus
herpesvirus
strain
influenzavirus
respiratori
syncyti
viru
detail
studi
viru
spectrum
cell
progress
report
separ
